Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients

Alzheimer's and Dementia

Volumn 5, Issue 2, 2009, Pages 143-146

  Simpkins, James W ^a   Gatson, Joshua W ^b   Wigginton, Jane G ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOOTROPIC AGENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; EVIDENCE BASED PRACTICE; HUMAN; INTERDISCIPLINARY COMMUNICATION; NEUROPATHOLOGY; NONHUMAN; PATIENT CARE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 62849129034     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.01.013     Document Type: Note

References (46)

1. Aisen P., Albert M., Breitner J.C.S., Buckholtz N., Corey-Bloom J.P., Cummings J.L., et al. Preventing dementia: following in Leon Thal's footsteps. Alzheimers Dement 4 (2008) 156-163
2. Szczygielski J., Mautes A., Steudel W.I., Falkai P., Bayer T.A., and Wirths O. Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies. J Neural Transm 112 (2005) 1547-1564
3. Fleminger S., Oliver D.L., Lovestone S., Rabe-Hesketh S., and Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74 (2003) 857-862
4. Roberts G.W., Gentleman S.M., Lynch A., and Graham D.I. Beta A4 amyloid protein deposition in brain after head trauma. Lancet 338 (1991) 1422-1423
5. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., and Graham D.I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 57 (1994) 419-425
6. Smith D.H., Chen X.H., Iwata A., and Graham D.I. Amyloid beta accumulation in axons after traumatic brain injury in humans. J Neurosurg 98 (2003) 1072-1077
7. McKenzie K.J., McLellan D.R., Gentleman S.M., Maxwell W.L., Gennarelli T.A., and Graham D.I. Is beta-APP a marker of axonal damage in short-surviving head injury?. Acta Neuropathol (Berl) 92 (1996) 608-613
8. Ikonomovic M.D., Uryu K., Abrahamson E.E., Ciallella J.R., Trojanowski J.Q., Lee V.M., et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190 (2004) 192-203
9. Lewen A., Li G.L., Olsson Y., and Hillered L. Changes in microtubule-associated protein 2 and amyloid precursor protein immunoreactivity following traumatic brain injury in rat: influence of MK-801 treatment. Brain Res 719 (1996) 161-171
10. Otsuka N., Tomonaga M., and Ikeda K. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 568 (1991) 335-338
11. Pierce J.E., Trojanowski J.Q., Graham D.I., Smith D.H., and McIntosh T.K. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J Neurosci 16 (1996) 1083-1090
12. Albensi B.C., Igoechi C., Janigro D., and Ilkanich E. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?. Am J Alzheimers Dis Other Dement 19 (2004) 269-274
13. Chen X.H., Siman R., Iwata A., Meaney D.F., Trojanowski J.Q., and Smith D.H. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol 165 (2004) 357-371
14. Hamberger A., Huang Y.L., Zhu H., et al. Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head. J Neurotrauma 20 (2003) 169-178
15. Brody D.L., and Holtzman D.M. Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197 (2006) 330-340
16. Hartman R.E., Laurer H., Longhi L., Bales K.R., Paul S.M., McIntosh T.K., et al. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J Neurosci 22 (2002) 10083-10087
17. Laurer H.L., Bareyre F.M., Lee V.M., Trojanowski J.Q., Longhi L., Hoover R., et al. Mild head injury increasing the brain's vulnerability to a second concussive impact. J Neurosurg 95 (2001) 859-870
18. Nakagawa Y., Nakamura M., McIntosh T.K., Rodriguez A., Berlin J.A., Smith D.H., et al. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J Comp Neurol 411 (1999) 390-398
19. Nakagawa Y., Reed L., Nakamura M., McIntosh T.K., Smith D.H., Saatman K.E., et al. Brain trauma in aged transgenic mice induces regression of established Abeta deposits. Exp Neurol 163 (2000) 244-252
20. Smith D.H., Nakamura M., McIntosh T.K., Trojanowski J.Q., Longhi L., Hoover R., et al. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 153 (1998) 1005-1010
21. Blasko I., Beer R., Bigl M., Apelt J., Franz G., Rudzki D., et al. Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1). J Neural Transm 111 (2004) 523-536
22. Gabbita S.P., Scheff S.W., Menard R.M., Roberts K., Fugaccia I., and Zemlan F.P. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 22 (2005) 83-94
23. Genis L., Chen Y., Shohami E., and Michaelson D.M. Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury. J Neurosci Res 60 (2000) 559-564
24. Irving E.A., Nicoll J., Graham D.I., and Dewar D. Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury. Neurosci Lett 213 (1996) 189-192
25. Tatemichi T.K., Foulkes M.A., Mohr J.P., Hewitt J.R., Hier D.B., Price T.R., et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21 (1990) 858-866
26. Bornstein N.M., Gur A.Y., Treves T.A., Reider-Groswasser I., Aronovich B.D., Klimovitzky S.S., et al. Do silent brain infarctions predict the development of dementia after first ischemic stroke?. Stroke 27 (1996) 904-905
27. Henon H., Durieu I., Guerouaou D., Lebert F., Pasquier F., and Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57 (2001) 1216-1222
28. Altieri M., Di Piero V., Pasquini M., Gasparini M., Vanacore N., Vicenzini E., et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 62 (2004) 2193-2197
29. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.P., and Beard C.M. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 46 (1996) 154-159
30. Desmond D.W., Moroney J.T., Sano M., and Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33 (2002) 2254-2260
31. Samuelsson M., Soderfeldt B., and Olsson G.B. Functional outcome in patients with lacunar infarction. Stroke 27 (1996) 842-846
32. Loeb C., Gandolfo C., Croce R., and Conti M. Dementia associated with lacunar infarction. Stroke 23 (1992) 1225-1229
33. Dewar D., Graham D.I., Teasdale G.M., and McCulloch J. Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. Acta Neuropathol (Berl) 86 (1993) 623-629
34. Wen Y., Yang S., Liu R., and Simpkins J.W. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res 1022 (2004) 30-38
35. Ikeda K., Akiyama H., Arai T., Kondo H., Haga C., Tsuchiya K., et al. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?. Neurosc Lett 284 (2000) 187-189
36. Wen Y., Yang S.H., Liu R., Brun-Zinkernagel A.M., Koulen P., and Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle reentry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem 279 (2004) 22684-22692
37. Wen Y., Yang S.H., Liu R., Sarkar S., and Simpkins J.W. Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett 579 (2005) 4591-4599
38. Wen Y., Yang S.H., Liu R., Perez E., Brun-Zinkernagel A.M., Koulen P., et al. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772 (2007) 473-483
39. Wen Y., Onyewuchi O., Yang S.H., Liu R., and Simpkins J.W. Increased β-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009 (2004) 1-8
40. Tesco G., Koh Y.H., Kang E., Cameron A., Das S., Sena-Esteves M., et al. Depletion of GGA3 stabilizes BACE and enhances β-secretase activity. Neuron 54 (2007) 721-737
41. Kesavapany S., Li B.S., Amin N., Zheng Y.L., Grant P., and Pant H.C. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 1697 (2004) 143-153
42. Mitsios N., Pennucci R., Krupinski J., Sanfeliu C., Gaffney J., Kumar P., et al. Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol 17 (2007) 11-23
43. Cruz J.C., and Tsai L.H. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10 (2004) 452-458
44. Monaco III E.A., and Vallano M.L. Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease. Front Biosci 10 (2005) 143-159
45. Wen Y., Yu W.H., Maloney B., Bailey J., Ma J., Marié I., et al. Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57 (2008) 680-690
46. Vassar R. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease. Neuron 54 (2007) 671-673